280 related articles for article (PubMed ID: 16763664)
1. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.
Moffatt S; Wiehle S; Cristiano RJ
Gene Ther; 2006 Nov; 13(21):1512-23. PubMed ID: 16763664
[TBL] [Abstract][Full Text] [Related]
2. Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.
Moffatt S; Papasakelariou C; Wiehle S; Cristiano R
Gene Ther; 2006 May; 13(9):761-72. PubMed ID: 16453011
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13.
Moffatt S; Wiehle S; Cristiano RJ
Hum Gene Ther; 2005 Jan; 16(1):57-67. PubMed ID: 15703489
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
5. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
[TBL] [Abstract][Full Text] [Related]
6. Viral and non-viral vectors for cancer gene therapy.
Cristiano RJ
Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
Moore NM; Sheppard CL; Sakiyama-Elbert SE
Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeting non-viral vector based on polyethylenimine improves gene transfer efficiency.
Li D; Tang GP; Li JZ; Kong Y; Huang HL; Min LJ; Zhou J; Shen FP; Wang QQ; Yu H
J Biomater Sci Polym Ed; 2007; 18(5):545-60. PubMed ID: 17550658
[TBL] [Abstract][Full Text] [Related]
9. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
10. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
Gautam A; Densmore CL; Waldrep JC
Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
[TBL] [Abstract][Full Text] [Related]
12. Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model.
Sweeney P; Karashima T; Ishikura H; Wiehle S; Yamashita M; Benedict WF; Cristiano RJ; Dinney CP
Cancer Res; 2003 Jul; 63(14):4017-20. PubMed ID: 12874000
[TBL] [Abstract][Full Text] [Related]
13. Systemic co-administration of depsipeptide selectively targets transfection enhancement to specific tissues and cell types.
Liu Y; Liggitt D; Fong S; Debs RJ
Gene Ther; 2006 Dec; 13(24):1724-30. PubMed ID: 16886001
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors.
Carlisle RC; Bettinger T; Ogris M; Hale S; Mautner V; Seymour LW
Mol Ther; 2001 Nov; 4(5):473-83. PubMed ID: 11708884
[TBL] [Abstract][Full Text] [Related]
15. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
16. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localisation and pDNA condensation in non-viral gene delivery.
Collins E; Birchall JC; Williams JL; Gumbleton M
J Gene Med; 2007 Apr; 9(4):265-74. PubMed ID: 17397103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
